Womens Imaging: Page 174

Low-cost ultrasound viable in underresourced settings
By Kate Madden Yee
Friday, November 30 | 11:00 a.m.-11:10 a.m. | SST04-04 | Room E260A new, low-cost ultrasound device offers an effective way to perform second-trimester fetal imaging, even by inexperienced users, according to Duke University researchers.
November 4, 2018
5-point quality score improves breast SWE performance
By Kate Madden Yee
Tuesday, November 27 | 11:20 a.m.-11:30 a.m. | SSG01-06 | Room S406AUsing a simple five-point technical quality scale can help radiologists better use shear-wave elastography (SWE) data, according to scientific research to be highlighted on Tuesday morning.
November 4, 2018
BI-RADS 3 lesions can be tracked in longer increments
By Kate Madden Yee
Tuesday, November 27 | 10:50 a.m.-11:00 a.m. | SSG01-03 | Room S406AIt's safe to track BI-RADS 3 lesions found on ultrasound at 12 months, rather than six, U.S. researchers will report in this presentation.
November 4, 2018
Breast ultrasound performs well over time
By Kate Madden Yee
Tuesday, November 27 | 10:30 a.m.-10:40 a.m. | SSG01-01 | Room S406AScreening breast ultrasound performs well over the long haul, which is good news in an era when more U.S. states are enacting breast density notification legislation that recommends women with dense tissue undergo supplemental screening.
November 4, 2018
Ultrasound tomo beats handheld sonography for gauging tumor volume
By Kate Madden Yee
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA20-04 | Room S102CDUltrasound tomography is better than handheld ultrasound when it comes to measuring breast tumor volume, researchers will report in this presentation.
November 4, 2018
Breast cancer mutation increases interval cancer risk
By AuntMinnie.com staff writers
Women who carry a certain rare breast cancer mutation are more likely to develop interval cancers than women who do not, according to a study published in the November issue of Cancer Research, a journal of the American Association for Cancer Research.
October 31, 2018
2017 09 14 23 05 1167 Cancer Cell 400
Social media is key to screening mammography education
By Kate Madden Yee
What kind of questions or concerns do women have when it comes to screening mammography? Social media is a good way to find out, according to a study published in the October issue of the Journal of the American College of Radiology.
October 31, 2018
2016 09 06 13 31 23 491 Question Mark Blue 400
FDA files action against Nev. imaging center for mammography
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has issued an adverse event warning for a Nevada imaging facility, Osteopathic Medical Assoc. of Las Vegas.
October 30, 2018
2016 09 02 09 36 05 93 Fda Logo V2 400
Study finds low reintervention rate for UAE of fibroids
By Kate Madden Yee
While uterine artery embolization (UAE) has proved an effective interventional radiology treatment for fibroids, concerns remain about reintervention rates years after the initial treatment. Fortunately, a new study has found that UAE reintervention rates are lower than previously thought.
October 30, 2018
2018 10 30 22 10 4516 Fibroid 400
Breast MRI may be good for intermediate-risk women
By Kate Madden Yee
Wednesday, November 28 | 12:45 p.m.-1:15 p.m. | BR266-SD-WEB6 | Lakeside, BR Community, Station 6Screening breast MRI could be an effective tool for women with an intermediate risk of breast cancer, according to this poster being presented on Wednesday afternoon.
October 30, 2018
Breast MRI tops DBT-ABVS for cancer staging
By Kate Madden Yee
Tuesday, November 27 | 3:30 p.m.-3:40 p.m. | SSJ02-04 | Room E353CBreast MRI performs better for breast cancer treatment staging than the combination of digital breast tomosynthesis (DBT) and ultrasound automated breast volume scanning (ABVS) -- but the latter works well enough to offer patients an alternative if MRI isn't available, Italian researchers have found.
October 30, 2018
Breast MRI with gadolinium contrast is safe for women
By Kate Madden Yee
Sunday, November 25 | 1:00 p.m.-1:30 p.m. | BR224-SD-SUB1 | Lakeside, BR Community, Station 1Breast MRI with macrocyclic gadolinium-based contrast agents does not put women at risk for deposits of the agent in the brain, according to this scientific poster being presented on Sunday afternoon.
October 30, 2018
Previous Page
Page 174 of 692
Next Page